QuidelOrtho Appoints Erich Wolff as Executive Vice President of Strategy and Corporate Development

QuidelOrtho Corporation Expands Leadership with New Executive

QuidelOrtho Corporation, a leading player in the in vitro diagnostics space, has strengthened its executive team by welcoming Erich Wolff as the new Executive Vice President for Strategy and Corporate Development. Based in San Diego, QuidelOrtho is committed to enhancing the future of diagnostics and expanding its global presence, and Mr. Wolff's extensive background makes him an ideal addition to this mission.

In his new role, Wolff will be responsible for overseeing the company’s enterprise strategy, business development efforts, government affairs, and the management of its diverse portfolio. Reporting to Brian Blaser, the company's President and CEO, his role will be crucial as QuidelOrtho aims to amplify its impact in the healthcare sector through innovative diagnostic solutions.

Wolff brings over 20 years of leadership experience in strategy, mergers and acquisitions, and business development across the healthcare and MedTech sectors. Prior to joining QuidelOrtho, he served as the Buyouts Lead for MedTech and Life Sciences Tools & Diagnostics at Partners Group, a renowned global private equity firm managing assets worth $174 billion. He has also held significant positions at major companies like BD and Medtronic, where he was integral to strategic initiatives that drove corporate development and innovation.

"Erich brings a rare combination of strategic vision, operational rigor, and transaction expertise," stated Blaser. His ability to navigate complex portfolio decisions and execute impactful growth strategies is expected to be invaluable. During his time at Medtronic, Wolff revived the global diabetes business and played a key role in corporate development for the company's significant neurosciences and diabetes units. His tenure at BD included instrumental contributions to key acquisitions and restructurings that shaped the future of the organization.

In expressing his enthusiasm about joining QuidelOrtho, Wolff stated, "It's an honor to come aboard at such a pivotal time. The company's compelling vision for the future of diagnostics, robust global footprint, and culture of innovation align perfectly with my professional aspirations. I'm eager to collaborate with Brian and the leadership team to develop and implement strategies that will stimulate growth and deliver substantial long-term value for our stakeholders."

Wolff holds a Bachelor of Business Administration in Finance and Economics from the University of Wisconsin-Milwaukee. His educational background complements his extensive professional experience, poised to contribute significantly to QuidelOrtho's strategic objectives and future growth.

QuidelOrtho is dedicated to developing and advancing innovative diagnostic solutions for better health outcomes. With its commitment to providing quick and reliable diagnostics across various settings—from hospitals to homes—the company is making strides in empowering healthcare professionals and patients alike. To learn more about QuidelOrtho and its initiatives, visit their official website and follow them on LinkedIn, Facebook, and X.

Conclusion

As QuidelOrtho gears up for the future of diagnostics, the addition of Erich Wolff heralds a new era of strategic direction and corporate development. With proven expertise in guiding healthcare organizations through transformative phases, Wolff is set to make a significant impact on the company's evolution and its contributions to global health. The industry will be watching closely as QuidelOrtho continues its journey toward a healthier future through innovation and excellence in diagnostics.